EQ Iron Condor Strategy
EQ (Equillium, Inc.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.
Equillium, Inc. is a clinical-stage biopharmaceutical company focused on developing and bringing to market products designed to address severe autoimmune and inflammatory (immuno-inflammatory) disorders where current treatment options are insufficient. The company's primary drug candidate is itolizumab (EQ001), a monoclonal antibody in clinical development that targets the novel CD6 immune checkpoint receptor. Itolizumab is currently in Phase III trials for acute graft-versus-host disease, has completed Phase Ib studies for asthma, and is also undergoing Phase Ib trials for lupus nephritis. In addition to itolizumab, Equillium is advancing EQ101 for the treatment of cutaneous T cell lymphoma and alopecia areata, and EQ102, which targets various gastrointestinal conditions. Headquartered in La Jolla, California, the company was incorporated in 2017 and previously operated as Attenuate Biopharmaceuticals, Inc. before changing its name to Equillium, Inc. in May 2017.
EQ (Equillium, Inc.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $108.3M, a beta of 1.78 versus the broader market, a 52-week range of 0.29-3.45, average daily share volume of 605K, a public-listing history dating back to 2018, approximately 35 full-time employees. These structural characteristics shape how EQ stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 1.78 indicates EQ has historically moved more than the broader market, amplifying both the directional payoff and the realized volatility relative to an index-equivalent position.
What is a iron condor on EQ?
An iron condor sells a call spread and a put spread at strikes outside spot, collecting net premium that is kept if the underlying stays inside the inner short strikes.
Current EQ snapshot
As of June 29, 2026, spot at $3.08, ATM IV 171.60%, IV rank 30.48%, expected move 49.20%. The iron condor on EQ below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 18-day expiry.
Why this iron condor structure on EQ specifically: EQ IV at 171.60% is mid-range versus its 1-year history, so the credit collected on a EQ iron condor sits in line with its long-run distribution, with a market-implied 1-standard-deviation move of approximately 49.20% (roughly $1.52 on the underlying). The 18-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated EQ expiries trade a higher absolute premium for lower per-day decay. Position sizing on EQ should anchor to the underlying notional of $3.08 per share and to the trader's directional view on EQ stock.
EQ iron condor setup
The EQ iron condor below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With EQ near $3.08, the first option leg uses a $3.23 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed EQ chain at a 18-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 EQ shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Sell 1 | Call | $3.23 | N/A |
| Buy 1 | Call | $3.39 | N/A |
| Sell 1 | Put | $2.93 | N/A |
| Buy 1 | Put | $2.77 | N/A |
EQ iron condor risk and reward
- Net Premium / Debit
- N/A
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- Unbounded
- Breakeven(s)
- None on modeled curve
- Risk / Reward Ratio
- N/A
Max profit equals the net credit times 100 inside the inner strikes; max loss equals wing width minus credit times 100. Two breakevens at inner strikes plus and minus the credit.
EQ iron condor payoff curve
Modeled P&L at expiration across a range of underlying prices for the iron condor on EQ. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
When traders use iron condor on EQ
Iron condors on EQ are a delta-neutral premium-collection structure that profits if EQ stock stays inside the inner short strikes; short strikes typically sit near 1 standard deviation from spot.
EQ thesis for this iron condor
The market-implied 1-standard-deviation range for EQ extends from approximately $1.56 on the downside to $4.60 on the upside. A EQ iron condor is a delta-neutral premium-collection structure that pays off when EQ stays inside the inner short strikes through expiration; the wing width should reflect the trader's tolerance for the maximum loss scenario where the underlying breaches an outer strike. Current EQ IV rank near 30.48% is mid-range against its 1-year distribution, so the IV signal is neutral; the iron condor thesis on EQ should anchor more to the directional view and the expected-move geometry. As a Healthcare name, EQ options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to EQ-specific events.
EQ iron condor positions are structurally neutral / range-bound; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. EQ positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move EQ alongside the broader basket even when EQ-specific fundamentals are unchanged. Short-premium structures like a iron condor on EQ carry tail risk when realized volatility exceeds the implied move; review historical EQ earnings reactions and macro stress periods before sizing. Always rebuild the position from current EQ chain quotes before placing a trade.
Frequently asked questions
- What is a iron condor on EQ?
- A iron condor on EQ is the iron condor strategy applied to EQ (stock). The strategy is structurally neutral / range-bound: An iron condor sells a call spread and a put spread at strikes outside spot, collecting net premium that is kept if the underlying stays inside the inner short strikes. With EQ stock trading near $3.08, the strikes shown on this page are snapped to the nearest listed EQ chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are EQ iron condor max profit and max loss calculated?
- Max profit equals the net credit times 100 inside the inner strikes; max loss equals wing width minus credit times 100. Two breakevens at inner strikes plus and minus the credit. For the EQ iron condor priced from the end-of-day chain at a 30-day expiry (ATM IV 171.60%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a EQ iron condor?
- The breakeven for the EQ iron condor priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current EQ market-implied 1-standard-deviation expected move is approximately 49.20%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a iron condor on EQ?
- Iron condors on EQ are a delta-neutral premium-collection structure that profits if EQ stock stays inside the inner short strikes; short strikes typically sit near 1 standard deviation from spot.
- How does current EQ implied volatility affect this iron condor?
- EQ ATM IV is at 171.60% with IV rank near 30.48%, which is mid-range against its 1-year history. Strategy selection depends more on directional thesis and expected move than on a strong IV signal.